The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weightmanagement.
Self-measurement used to be difficult and expensive but technologists have started solving these issues: leaders include FitBit and Zeo for sleep measurement, RunKeeper for exercise tracking and Withings for weightmanagement.
Lorcaserin, brand name Belviq (pronounced BEL-VEEK), is conditionally approved in the U.S. for chronic weightmanagement in obese or overweight adults when used together with a reduced-calorie diet and exercise.